158 related articles for article (PubMed ID: 28733338)
1. Early and lethal neurodegeneration with myasthenic and myopathic features: A new
Schorling DC; Rost S; Lefeber DJ; Brady L; Müller CR; Korinthenberg R; Tarnopolsky M; Bönnemann CG; Rodenburg RJ; Bugiani M; Beytia M; Krüger M; van der Knaap M; Kirschner J
Neurology; 2017 Aug; 89(7):657-664. PubMed ID: 28733338
[TBL] [Abstract][Full Text] [Related]
2. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
Cossins J; Belaya K; Hicks D; Salih MA; Finlayson S; Carboni N; Liu WW; Maxwell S; Zoltowska K; Farsani GT; Laval S; Seidhamed MZ; ; Donnelly P; Bentley D; McGowan SJ; Müller J; Palace J; Lochmüller H; Beeson D
Brain; 2013 Mar; 136(Pt 3):944-56. PubMed ID: 23404334
[TBL] [Abstract][Full Text] [Related]
3. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.
Morava E; Tiemes V; Thiel C; Seta N; de Lonlay P; de Klerk H; Mulder M; Rubio-Gozalbo E; Visser G; van Hasselt P; Horovitz DDG; de Souza CFM; Schwartz IVD; Green A; Al-Owain M; Uziel G; Sigaudy S; Chabrol B; van Spronsen FJ; Steinert M; Komini E; Wurm D; Bevot A; Ayadi A; Huijben K; Dercksen M; Witters P; Jaeken J; Matthijs G; Lefeber DJ; Wevers RA
J Inherit Metab Dis; 2016 Sep; 39(5):713-723. PubMed ID: 27287710
[TBL] [Abstract][Full Text] [Related]
4. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
5. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.
Iqbal Z; Shahzad M; Vissers LE; van Scherpenzeel M; Gilissen C; Razzaq A; Zahoor MY; Khan SN; Kleefstra T; Veltman JA; de Brouwer AP; Lefeber DJ; van Bokhoven H; Riazuddin S
Eur J Hum Genet; 2013 Aug; 21(8):844-9. PubMed ID: 23249953
[TBL] [Abstract][Full Text] [Related]
6. Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.
Hamici S; Bastaki F; Khalifa M
Eur J Med Genet; 2017 Oct; 60(10):541-547. PubMed ID: 28778787
[TBL] [Abstract][Full Text] [Related]
7. The longest reported sibling survivors of a severe form of congenital myasthenic syndrome with the ALG14 pathogenic variant.
Katata Y; Uneoka S; Saijyo N; Aihara Y; Miyazoe T; Koyamaishi S; Oikawa Y; Ito Y; Abe Y; Numata-Uematsu Y; Takayama J; Kikuchi A; Tamiya G; Uematsu M; Kure S
Am J Med Genet A; 2022 Apr; 188(4):1293-1298. PubMed ID: 34971077
[TBL] [Abstract][Full Text] [Related]
8. Immune dysfunction in MGAT2-CDG: A clinical report and review of the literature.
Poskanzer SA; Schultz MJ; Turgeon CT; Vidal-Folch N; Liedtke K; Oglesbee D; Gavrilov DK; Tortorelli S; Matern D; Rinaldo P; Bennett JT; Thies JM; Chang IJ; Beck AE; Raymond K; Allenspach EJ; Lam C
Am J Med Genet A; 2021 Jan; 185(1):213-218. PubMed ID: 33044030
[TBL] [Abstract][Full Text] [Related]
9. Expanding the clinical and metabolic phenotype of DPM2 deficient congenital disorders of glycosylation.
Radenkovic S; Fitzpatrick-Schmidt T; Byeon SK; Madugundu AK; Saraswat M; Lichty A; Wong SYW; McGee S; Kubiak K; Ligezka A; Ranatunga W; Zhang Y; Wood T; Friez MJ; Clarkson K; Pandey A; Jones JR; Morava E
Mol Genet Metab; 2021 Jan; 132(1):27-37. PubMed ID: 33129689
[TBL] [Abstract][Full Text] [Related]
10. A family with floppy neonates with severe respiratory insufficiency: A lethal phenotype of RFT1-CDG due to a novel mutation.
Abiramalatha T; Arunachal G; Muthusamy K; Thomas N
Eur J Med Genet; 2019 Apr; 62(4):248-253. PubMed ID: 30071302
[TBL] [Abstract][Full Text] [Related]
11. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
[TBL] [Abstract][Full Text] [Related]
12. A novel ALG14 missense variant in an alive child with myopathy, epilepsy, and progressive cerebral atrophy.
Palombo F; Piccolo B; Saccani E; Fiorini C; Capristo M; Caporali L; Pisani F; Carelli V
Am J Med Genet A; 2021 Jun; 185(6):1918-1921. PubMed ID: 33751823
[No Abstract] [Full Text] [Related]
13. Genomic screening in rare disorders: New mutations and phenotypes, highlighting ALG14 as a novel cause of severe intellectual disability.
Kvarnung M; Taylan F; Nilsson D; Anderlid BM; Malmgren H; Lagerstedt-Robinson K; Holmberg E; Burstedt M; Nordenskjöld M; Nordgren A; Lundberg ES
Clin Genet; 2018 Dec; 94(6):528-537. PubMed ID: 30221345
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndrome.
Monies DM; Al-Hindi HN; Al-Muhaizea MA; Jaroudi DJ; Al-Younes B; Naim EA; Wakil SM; Meyer BF; Bohlega S
Neuromuscul Disord; 2014 Apr; 24(4):353-9. PubMed ID: 24461433
[TBL] [Abstract][Full Text] [Related]
15. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
[TBL] [Abstract][Full Text] [Related]
16. MAN1B-CDG: Novel variants with a distinct phenotype and review of literature.
Balasubramanian M; Johnson DS;
Eur J Med Genet; 2019 Feb; 62(2):109-114. PubMed ID: 29908352
[TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenia and congenital disorders of glycosylation caused by mutations in the DPAGT1 gene.
Ibáñez-Micó S; Domingo Jiménez R; Pérez-Cerdá C; Ghandour-Fabre D
Neurologia (Engl Ed); 2019 Mar; 34(2):139-141. PubMed ID: 28712839
[No Abstract] [Full Text] [Related]
18. Structural Analysis of the Effect of Asn107Ser Mutation on Alg13 Activity and Alg13-Alg14 Complex Formation and Expanding the Phenotypic Variability of ALG13-CDG.
Mitusińska K; Góra A; Bogdańska A; Rożdżyńska-Świątkowska A; Tylki-Szymańska A; Jezela-Stanek A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327592
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
[TBL] [Abstract][Full Text] [Related]
20. Adult phenotype and further phenotypic variability in SRD5A3-CDG.
Kara B; Ayhan Ö; Gökçay G; Başboğaoğlu N; Tolun A
BMC Med Genet; 2014 Jan; 15():10. PubMed ID: 24433453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
